Insider Trading June 26, 2026 06:30 PM

Huntington Bancshares Executive Disposes of $190K in Stock Under Pre-Arranged Plan

General Counsel Marcy Hingst’s transaction follows a robust first-quarter earnings beat and shareholder approvals at the 2026 Annual Meeting.

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
HBAN

Huntington Bancshares Inc. (NASDAQ: HBAN) reported that its Senior Executive Vice President and General Counsel, Marcy C. Hingst, executed a sale of company stock on June 25, 2026. The transaction, valued at $190,224, was carried out through an automated trading plan adopted earlier in the year. This financial move occurs against a backdrop of strong first-quarter 2026 financial performance, which significantly exceeded analyst consensus, and the recent ratification of board leadership at the company’s 2026 Annual Meeting of Shareholders.

Huntington Bancshares Executive Disposes of $190K in Stock Under Pre-Arranged Plan
HBAN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Huntington Bancshares reported a significant first-quarter 2026 earnings beat, with adjusted EPS of $0.37 surpassing estimates of $0.23 by 60.87%, and revenue reaching $2.59 billion.
  • SEVP and General Counsel Marcy Hingst sold 10,568 shares at $18.00 per share under a Rule 10b5-1 plan adopted in March 2025, retaining over 267,000 shares.
  • At the 2026 Annual Meeting, shareholders approved executive pay and elected directors including Ann B. Crane, Rafael A. Diaz-Granados, and Virginia A. Hepner.

Marcy C. Hingst, serving in the dual capacity of Senior Executive Vice President and General Counsel at Huntington Bancshares Inc. (NASDAQ: HBAN), has completed a significant transaction involving the company's equity. According to filings submitted to the Securities and Exchange Commission, Hingst offloaded a portion of her holdings on June 25, 2026. The total value derived from this disposition reached $190,224.

The transaction involved the disposal of exactly 10,568 shares of Huntington Bancshares common stock. These shares were sold at a uniform price point of $18.00 per share. The execution of this sale was not discretionary in real-time but was automated, adhering to the parameters of a Rule 10b5-1 trading plan. This specific plan was originally established and adopted by Ms. Hingst on March 13, 2025, providing a structured framework for her equity transactions.

Following the conclusion of this sale, Ms. Hingst’s direct ownership stake in the company remains substantial. The SEC filing indicates that she continues to hold 267,859.194 shares of Huntington Bancshares common stock. The execution price of $18.00 per share for this transaction was marginally higher than the prevailing market valuation, which stood at $17.81 at the time of reporting. Market analysis from InvestingPro suggests that the stock may be trading below its intrinsic fair value assessment, potentially indicating an undervaluation relative to fundamental metrics.

The financial context surrounding this insider activity reflects a period of robust operational performance for Huntington Bancshares. The institution recently reported financial results for the first quarter of 2026 that surpassed the expectations of market analysts. The company posted an adjusted earnings per share (EPS) of $0.37. This figure represented a significant deviation from the anticipated $0.23, marking a positive surprise of 60.87%. Revenue performance also outpaced forecasts, reaching $2.59 billion compared to the projected $2.57 billion, underscoring the company's strategic execution during the period.

Corporate governance matters were also addressed during the company’s 2026 Annual Meeting of Shareholders. During this gathering, shareholders approved all proposed directors and executive compensation packages. The election results confirmed the board membership of several key figures, including Ann B. Crane, Rafael A. Diaz-Granados, and Virginia A. Hepner, alongside other directors.

Valuation metrics for Huntington Bancshares present a profile of stability and income generation. The stock currently trades at a price-to-earnings (P/E) ratio of 13.86. The institution maintains a dividend yield of 3.49%, a return that has been sustained through 56 consecutive years of uninterrupted dividend payments. For investors seeking comprehensive data, InvestingPro provides a detailed Pro Research Report on HBAN, which is part of a broader coverage encompassing over 1,400 US equities.

Risks

  • The sale of stock by an executive, while executed under a pre-arranged 10b5-1 plan, may be monitored by the market for signals regarding internal liquidity needs or valuation perceptions.
  • While the stock is described as undervalued based on fair value assessment, the current trading price of $17.81 indicates ongoing market fluctuations that could impact investor sentiment.

More from Insider Trading

Personalis CFO Tachibana Executes $675K Stock Sale Under Pre-Approved Plan Jun 26, 2026 Slide Insurance Director Andrew Wright Executes Pre-Arranged Stock Sales Jun 26, 2026 Immunovant CTO Jay Stout Offloads $1.53M in Stock Ahead of Analyst Upgrades Jun 26, 2026 Personalis CEO Christopher Hall Executes $1.31M Stock Sale Under Pre-Arranged Plan Jun 26, 2026 Immunovant Executive Trims Holdings as Stock Nears Peak Valuation Jun 26, 2026